Ajer Jeffrey Robert
Insider CIK 1557533 · BMRN SVP, Chief Commercial Officer · VRDN Director · NKTR Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NKTR NEKTAR THERAPEUTICS | A Award deriv | 2026-09-23 | 2026-09-25 | 4,000 | — | $0 | 4,000 | SEC↗ |
| NKTR NEKTAR THERAPEUTICS | A Award | 2026-09-23 | 2026-09-25 | 2,000 | — | $0 | 4,277 | SEC↗ |
| NKTR NEKTAR THERAPEUTICS | A Award deriv | 2026-09-23 | 2026-09-25 | 4,000 | — | $0 | 4,000 | SEC↗ |
| NKTR NEKTAR THERAPEUTICS | A Award | 2026-09-23 | 2026-09-25 | 2,000 | — | $0 | 4,277 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | A Award deriv | 2026-07-01 | 2026-07-02 | 32,341 | — | $0 | 32,341 | SEC↗ |
| NKTR NEKTAR THERAPEUTICS | A Award deriv | 2025-09-30 | 2025-10-01 | 8,000 | — | $0 | 8,000 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | A Award deriv | 2025-07-01 | 2025-07-02 | 21,000 | — | $0 | 21,000 | SEC↗ |
| VRDN Viridian Therapeutics, Inc | A Award deriv | 2025-04-07 | 2025-04-09 | 42,000 | — | $0 | 42,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2024-05-02 | 2024-05-06 | 5,000 | $82.91 | $414.6K | 66,767 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2024-04-30 | 2024-05-06 | 300 | $68.65 | $20.6K | 71,767 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2024-03-15 | 2024-03-19 | 22,580 | $83.87 | $1.89M | 71,467 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2024-03-05 | 2024-03-07 | 4,000 | $87.07 | $348.3K | 94,047 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2024-02-27 | 2024-02-29 | 21,440 | — | $0 | 82,244 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2024-02-27 | 2024-02-29 | 6,465 | — | $0 | 98,047 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2024-02-27 | 2024-02-29 | 9,338 | — | $0 | 91,582 | SEC↗ |
| NKTR NEKTAR THERAPEUTICS | A Award deriv | 2023-09-19 | 2023-09-20 | 85,000 | — | $0 | 85,000 | SEC↗ |
| NKTR NEKTAR THERAPEUTICS | S Sale | 2023-09-18 | 2023-09-20 | 4,359 | $0.69 | $3.0K | 34,153 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2023-08-16 | 2023-08-17 | 5,000 | $90.00 | $450.0K | 60,804 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2023-04-28 | 2023-08-17 | 318 | $66.88 | $21.3K | 65,804 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2023-03-16 | 2023-03-17 | 20,510 | $93.41 | $1.92M | 65,486 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2023-03-15 | 2023-03-17 | 23,070 | — | $0 | 23,070 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2023-03-15 | 2023-03-17 | 3,971 | $87.74 | $348.4K | 85,996 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2023-03-15 | 2023-03-17 | 10,110 | — | $0 | 89,967 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2023-02-28 | 2023-03-02 | 7,629 | — | $0 | 79,857 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2023-02-28 | 2023-03-02 | 10,380 | — | $0 | 72,228 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2023-02-28 | 2023-03-02 | 20,760 | — | $0 | 61,848 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2023-01-25 | 2023-01-27 | 46,800 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2023-01-25 | 2023-01-27 | 2,200 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2023-01-25 | 2023-01-27 | 49,000 | $67.81 | $3.32M | 90,088 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2023-01-25 | 2023-01-27 | 44,825 | $115.65 | $5.18M | 45,263 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2023-01-25 | 2023-01-27 | 4,175 | $116.15 | $484.9K | 41,088 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2022-11-02 | 2022-11-04 | 3,000 | $86.12 | $258.4K | 41,088 | SEC↗ |
| NKTR NEKTAR THERAPEUTICS | S Sale | 2022-09-23 | 2022-09-26 | 4,198 | $3.16 | $13.3K | 38,512 | SEC↗ |
| NKTR NEKTAR THERAPEUTICS | A Award deriv | 2022-09-16 | 2022-09-20 | 20,400 | — | $0 | 20,400 | SEC↗ |
| NKTR NEKTAR THERAPEUTICS | A Award | 2022-09-16 | 2022-09-20 | 10,200 | — | $0 | 42,710 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2022-08-11 | 2022-08-12 | 3,000 | $95.62 | $286.9K | 44,088 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2022-06-03 | 2022-06-07 | 7,021 | $77.49 | $544.1K | 47,088 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2022-05-26 | 2022-05-31 | 1,308 | $78.94 | $103.3K | 54,109 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2022-04-29 | 2022-05-31 | 340 | $62.41 | $21.2K | 55,417 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2022-04-13 | 2022-04-14 | 1,180 | $82.47 | $97.3K | 55,077 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2022-03-30 | 2022-03-31 | 1,381 | $79.56 | $109.9K | 56,257 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2022-03-29 | 2022-03-31 | 1,618 | $79.43 | $128.5K | 57,638 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2022-03-23 | 2022-03-24 | 6,129 | $81.78 | $501.2K | 59,256 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2022-03-22 | 2022-03-24 | 2,073 | $81.00 | $167.9K | 65,385 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2022-03-16 | 2022-03-17 | 1,287 | $80.72 | $103.9K | 67,458 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2022-03-15 | 2022-03-17 | 28,670 | — | $0 | 28,670 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2022-03-15 | 2022-03-17 | 8,418 | $78.27 | $658.9K | 68,745 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2022-03-15 | 2022-03-17 | 11,940 | — | $0 | 77,163 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2022-03-08 | 2022-03-10 | 9,370 | — | $0 | 65,223 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2021-10-26 | 2021-10-28 | 2,739 | $73.60 | $201.6K | 55,853 | SEC↗ |
| NKTR NEKTAR THERAPEUTICS | A Award deriv | 2021-09-22 | 2021-09-24 | 20,400 | — | $0 | 20,400 | SEC↗ |
| NKTR NEKTAR THERAPEUTICS | A Award | 2021-09-22 | 2021-09-24 | 10,200 | — | $0 | 36,175 | SEC↗ |
| NKTR NEKTAR THERAPEUTICS | S Sale | 2021-09-22 | 2021-09-24 | 3,665 | $17.78 | $65.2K | 32,510 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2021-04-30 | 2021-10-28 | 342 | $62.41 | $21.3K | 58,592 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2021-04-08 | 2021-04-09 | 1,537 | $78.81 | $121.1K | 58,250 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2021-03-30 | 2021-04-01 | 1,652 | $74.79 | $123.6K | 59,787 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2021-03-24 | 2021-03-26 | 1,181 | $76.30 | $90.1K | 61,439 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2021-03-22 | 2021-03-23 | 1,513 | $78.52 | $118.8K | 62,620 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2021-03-18 | 2021-03-19 | 1,308 | $77.99 | $102.0K | 64,133 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2021-03-16 | 2021-03-17 | 1,287 | $77.21 | $99.4K | 65,441 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2021-03-15 | 2021-03-17 | 26,400 | — | $0 | 26,400 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2021-03-15 | 2021-03-17 | 5,273 | $78.39 | $413.4K | 66,728 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2021-03-15 | 2021-03-17 | 10,720 | — | $0 | 72,001 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2020-10-14 | 2020-10-15 | 2,121 | $79.91 | $169.5K | 61,281 | SEC↗ |
| NKTR NEKTAR THERAPEUTICS | S Sale | 2020-09-28 | 2020-09-30 | 3,250 | $17.25 | $56.1K | 25,975 | SEC↗ |
| NKTR NEKTAR THERAPEUTICS | A Award deriv | 2020-09-22 | 2020-09-24 | 18,200 | — | $0 | 18,200 | SEC↗ |
| NKTR NEKTAR THERAPEUTICS | A Award deriv | 2020-09-22 | 2020-09-25 | 18,200 | — | $0 | 18,200 | SEC↗ |
| NKTR NEKTAR THERAPEUTICS | A Award | 2020-09-22 | 2020-09-24 | 9,100 | — | $0 | 29,225 | SEC↗ |
| NKTR NEKTAR THERAPEUTICS | A Award | 2020-09-22 | 2020-09-25 | 9,100 | — | $0 | 29,225 | SEC↗ |
| NKTR NEKTAR THERAPEUTICS | S Sale | 2020-09-21 | 2020-09-21 | 2,250 | $19.74 | $44.4K | 20,125 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2020-06-19 | 2020-06-23 | 15,000 | — | $0 | 15,700 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2020-06-19 | 2020-06-23 | 15,000 | $124.00 | $1.86M | 63,402 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2020-06-19 | 2020-06-23 | 15,000 | $63.10 | $946.5K | 78,402 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2020-04-30 | 2020-06-23 | 338 | $62.59 | $21.2K | 63,402 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2020-04-08 | 2020-04-09 | 2,407 | $79.98 | $192.5K | 63,064 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2020-04-01 | 2020-04-02 | 1,537 | $82.00 | $126.0K | 65,471 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2020-03-25 | 2020-03-26 | 1,618 | $78.47 | $127.0K | 67,008 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2020-03-24 | 2020-03-26 | 2,041 | $74.36 | $151.8K | 68,626 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2020-03-20 | 2020-03-24 | 3,599 | $73.05 | $262.9K | 70,667 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2020-03-16 | 2020-03-17 | 29,590 | — | $0 | 29,590 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2020-03-16 | 2020-03-17 | 10,380 | — | $0 | 74,266 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2020-03-13 | 2020-03-17 | 7,644 | $84.50 | $645.9K | 63,886 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2020-03-03 | 2020-03-04 | 9,586 | — | $0 | 71,530 | SEC↗ |
| NKTR NEKTAR THERAPEUTICS | S Sale | 2019-09-30 | 2019-10-01 | 2,375 | $18.06 | $42.9K | 22,375 | SEC↗ |
| NKTR NEKTAR THERAPEUTICS | A Award deriv | 2019-09-25 | 2019-09-27 | 13,000 | — | $0 | 13,000 | SEC↗ |
| NKTR NEKTAR THERAPEUTICS | A Award | 2019-09-25 | 2019-09-27 | 6,500 | — | $0 | 24,750 | SEC↗ |
| NKTR NEKTAR THERAPEUTICS | S Sale | 2019-09-20 | 2019-09-24 | 2,250 | $20.24 | $45.5K | 18,250 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2019-06-05 | 2019-06-06 | 14,160 | — | $0 | 61,635 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2019-04-30 | 2019-06-07 | 309 | $68.78 | $21.3K | 61,994 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2019-03-26 | 2019-03-27 | 3,656 | $89.18 | $326.0K | 47,475 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2019-03-22 | 2019-03-26 | 3,598 | $88.05 | $316.8K | 51,131 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2019-03-21 | 2019-03-25 | 1,930 | $90.47 | $174.6K | 54,729 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2019-03-21 | 2019-03-25 | 2,589 | $89.62 | $232.0K | 56,659 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2019-03-19 | 2019-03-21 | 3,728 | $93.07 | $347.0K | 59,248 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2019-03-15 | 2019-03-19 | 23,450 | — | $0 | 23,450 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2019-03-15 | 2019-03-19 | 9,370 | — | $0 | 62,976 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2019-03-15 | 2019-03-19 | 7,169 | $94.53 | $677.7K | 53,606 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2019-03-01 | 2019-03-05 | 917 | $94.76 | $86.9K | 60,775 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2019-03-01 | 2019-03-05 | 12,557 | — | $0 | 61,692 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2018-11-14 | 2018-11-16 | 9,000 | — | $0 | 30,700 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2018-11-14 | 2018-11-16 | 600 | $94.35 | $56.6K | 49,135 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2018-11-14 | 2018-11-16 | 9,000 | $63.10 | $567.9K | 58,135 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2018-11-14 | 2018-11-16 | 5,201 | $91.62 | $476.5K | 52,934 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2018-11-14 | 2018-11-16 | 2,400 | $92.21 | $221.3K | 50,534 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2018-11-14 | 2018-11-16 | 799 | $93.81 | $75.0K | 49,735 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2018-10-03 | 2018-10-05 | 1,000 | $98.98 | $99.0K | 49,135 | SEC↗ |
| NKTR NEKTAR THERAPEUTICS | A Award deriv | 2018-09-27 | 2018-10-01 | 9,500 | — | $0 | 9,500 | SEC↗ |
| NKTR NEKTAR THERAPEUTICS | A Award | 2018-09-27 | 2018-10-01 | 4,750 | — | $0 | 20,500 | SEC↗ |
| NKTR NEKTAR THERAPEUTICS | S Sale | 2018-09-20 | 2018-09-21 | 6,750 | $56.76 | $383.1K | 15,750 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2018-06-11 | 2018-06-13 | 1,436 | $90.31 | $129.7K | 50,135 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2018-06-04 | 2018-06-06 | 1,414 | $92.07 | $130.2K | 51,571 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2018-05-07 | 2018-05-09 | 309 | $85.96 | $26.6K | 52,914 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2018-04-30 | 2018-05-09 | 309 | $68.78 | $21.3K | 53,223 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2018-04-02 | 2018-04-03 | 2,119 | $80.12 | $169.8K | 52,914 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2018-03-29 | 2018-03-30 | 1,537 | $79.69 | $122.5K | 55,033 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2018-03-22 | 2018-04-27 | 3,598 | $81.36 | $292.7K | 56,555 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2018-03-22 | 2018-03-26 | 3,583 | $81.36 | $291.5K | 56,570 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2018-03-21 | 2018-03-23 | 4,368 | $83.90 | $366.5K | 60,153 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2018-03-15 | 2018-03-19 | 41,040 | — | $0 | 41,040 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2018-03-15 | 2018-03-19 | 12,840 | — | $0 | 64,521 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2018-03-15 | 2018-03-19 | 3,651 | $83.57 | $305.1K | 51,681 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2018-03-09 | 2018-03-13 | 2,972 | $82.39 | $244.9K | 55,332 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2018-03-02 | 2018-03-06 | 1,614 | $79.86 | $128.9K | 58,304 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2018-02-26 | 2018-04-26 | 12,615 | — | $0 | 60,004 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2018-02-26 | 2018-02-28 | 12,529 | — | $0 | 59,918 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2017-09-22 | 2017-09-26 | 1,355 | — | $0 | 2,166 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2017-09-22 | 2017-09-26 | 2,166 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2017-09-22 | 2017-09-26 | 1,355 | $37.46 | $50.8K | 49,299 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2017-09-22 | 2017-09-26 | 2,166 | $95.00 | $205.8K | 47,944 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2017-09-22 | 2017-09-26 | 2,166 | $37.46 | $81.1K | 50,110 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2017-09-22 | 2017-09-26 | 1,355 | $95.00 | $128.7K | 47,944 | SEC↗ |
| NKTR NEKTAR THERAPEUTICS | A Award deriv | 2017-09-19 | 2017-09-21 | 22,500 | — | $0 | 22,500 | SEC↗ |
| NKTR NEKTAR THERAPEUTICS | A Award deriv | 2017-09-19 | 2017-09-21 | 33,750 | — | $0 | 33,750 | SEC↗ |
| NKTR NEKTAR THERAPEUTICS | A Award | 2017-09-19 | 2017-09-21 | 13,500 | — | $0 | 13,500 | SEC↗ |
| NKTR NEKTAR THERAPEUTICS | A Award | 2017-09-19 | 2017-09-21 | 9,000 | — | $0 | 22,500 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2017-06-07 | 2017-06-09 | 1,004 | $89.61 | $90.0K | 47,944 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2017-06-02 | 2017-06-06 | 1,488 | $90.72 | $135.0K | 48,948 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2017-05-15 | 2017-05-17 | 1,096 | $91.50 | $100.3K | 50,436 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2017-05-05 | 2017-05-09 | 988 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2017-05-05 | 2017-05-09 | 3,498 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2017-05-05 | 2017-05-09 | 988 | $28.23 | $27.9K | 52,520 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2017-05-05 | 2017-05-09 | 3,498 | $99.00 | $346.3K | 51,532 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2017-05-05 | 2017-05-09 | 3,498 | $38.59 | $135.0K | 55,030 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2017-05-05 | 2017-05-09 | 988 | $99.00 | $97.8K | 51,532 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2017-05-02 | 2017-05-04 | 302 | $96.74 | $29.2K | 51,532 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2017-04-28 | 2017-05-04 | 302 | $70.30 | $21.2K | 51,834 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2017-03-29 | 2017-03-31 | 3,890 | $89.15 | $346.8K | 51,532 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2017-03-22 | 2017-03-24 | 39,480 | — | $0 | 39,480 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2017-03-22 | 2017-03-24 | 12,200 | — | $0 | 55,422 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2017-03-15 | 2017-03-17 | 3,288 | $92.50 | $304.1K | 43,222 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2017-03-07 | 2017-03-08 | 5,000 | $90.56 | $452.8K | 46,510 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2017-03-03 | 2017-03-07 | 1,749 | $93.95 | $164.3K | 51,510 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2017-02-24 | 2017-02-28 | 11,917 | $95.61 | $1.14M | 53,259 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2016-09-27 | 2016-09-29 | 18,467 | $95.61 | $1.77M | 41,342 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2016-06-03 | 2016-06-07 | 1,488 | $90.00 | $133.9K | 59,809 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2016-05-13 | 2016-05-17 | 1,096 | $82.71 | $90.7K | 61,297 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2016-05-06 | 2016-05-12 | 679 | $80.80 | $54.9K | 62,393 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2016-05-03 | 2016-05-04 | 415 | $86.03 | $35.7K | 63,072 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2016-04-29 | 2016-05-04 | 415 | $51.26 | $21.3K | 63,487 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2016-03-15 | 2016-03-17 | 36,280 | — | $0 | 36,280 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2016-03-15 | 2016-03-17 | 16,190 | — | $0 | 63,072 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2016-03-04 | 2016-03-07 | 1,255 | $88.42 | $111.0K | 46,882 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2016-03-03 | 2016-03-07 | 2,395 | $89.57 | $214.5K | 48,137 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2016-02-29 | 2016-03-02 | 17,656 | $81.87 | $1.45M | 50,532 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2016-02-24 | 2016-02-26 | 6,860 | — | $0 | 42,465 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2016-02-24 | 2016-02-26 | 19,840 | — | $0 | 62,305 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2016-02-24 | 2016-02-26 | 5,883 | — | $0 | 68,188 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2015-11-02 | 2015-11-06 | 26 | $117.56 | $3.1K | 35,605 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2015-10-30 | 2015-11-06 | 26 | $57.26 | $1.5K | 35,631 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2015-07-20 | 2015-07-22 | 3,000 | — | $0 | 39,700 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2015-07-20 | 2015-07-22 | 3,000 | $63.10 | $189.3K | 38,605 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2015-07-20 | 2015-07-22 | 3,000 | $150.00 | $450.0K | 35,605 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2015-06-04 | 2015-06-08 | 1,362 | $122.35 | $166.6K | 35,605 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2015-06-04 | 2015-06-08 | 1,488 | $120.46 | $179.2K | 36,967 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2015-06-01 | 2015-06-03 | 377 | $123.76 | $46.7K | 38,455 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2015-05-31 | 2015-06-03 | 413 | $125.57 | $51.9K | 38,832 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2015-05-26 | 2015-05-26 | 1,625 | $126.55 | $205.6K | 39,245 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2015-05-15 | 2015-05-19 | 1,096 | $122.78 | $134.6K | 40,870 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2015-05-08 | 2015-05-12 | 679 | $121.66 | $82.6K | 41,966 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2015-05-06 | 2015-05-08 | 625 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2015-05-06 | 2015-05-08 | 808 | — | $0 | 1,355 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2015-05-06 | 2015-05-08 | 3,125 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2015-05-06 | 2015-05-08 | 2,642 | — | $0 | 978 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2015-05-06 | 2015-05-08 | 12,502 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2015-05-06 | 2015-05-08 | 8,671 | — | $0 | 2,166 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2015-05-06 | 2015-05-08 | 5,258 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2015-05-06 | 2015-05-08 | 2,642 | $28.23 | $74.6K | 61,927 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2015-05-06 | 2015-05-08 | 33,631 | $119.14 | $4.01M | 43,033 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2015-05-06 | 2015-05-08 | 8,671 | $37.46 | $324.8K | 76,664 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2015-05-06 | 2015-05-08 | 808 | $37.46 | $30.3K | 67,993 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2015-05-06 | 2015-05-08 | 5,258 | $28.23 | $148.4K | 67,185 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2015-05-06 | 2015-05-08 | 388 | $119.20 | $46.2K | 42,645 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2015-05-06 | 2015-05-08 | 3,125 | $21.51 | $67.2K | 59,285 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2015-05-06 | 2015-05-08 | 625 | $21.51 | $13.4K | 56,160 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2015-05-06 | 2015-05-08 | 12,502 | $38.59 | $482.5K | 55,535 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2015-04-30 | 2015-05-08 | 943 | $51.26 | $48.3K | 43,033 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2015-03-03 | 2015-03-05 | 23,900 | — | $0 | 23,900 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2015-03-03 | 2015-03-05 | 10,500 | — | $0 | 42,090 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2014-12-03 | 2014-12-05 | 12,000 | — | $0 | 12,502 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2014-12-03 | 2014-12-05 | 12,000 | $91.01 | $1.09M | 31,590 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2014-12-03 | 2014-12-05 | 12,000 | $38.59 | $463.1K | 43,590 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2014-11-03 | 2014-11-05 | 47 | $83.54 | $3.9K | 31,590 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2014-10-31 | 2014-11-05 | 47 | $31.26 | $1.5K | 31,637 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2014-06-04 | 2014-06-06 | 42,700 | — | $0 | 42,700 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2014-06-04 | 2014-06-06 | 11,400 | — | $0 | 31,590 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2014-06-02 | 2014-06-03 | 377 | $57.83 | $21.8K | 20,190 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2014-05-31 | 2014-06-02 | 413 | $57.96 | $23.9K | 20,567 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2014-05-16 | 2014-05-19 | 1,004 | $56.91 | $57.1K | 20,980 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2014-05-15 | 2014-05-16 | 1,096 | $57.44 | $63.0K | 21,984 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2014-05-13 | 2014-05-14 | 478 | $58.18 | $27.8K | 23,080 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2014-05-12 | 2014-05-14 | 522 | $59.30 | $31.0K | 23,558 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2014-05-09 | 2014-05-13 | 621 | $57.96 | $36.0K | 24,080 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2014-05-08 | 2014-05-12 | 679 | $56.78 | $38.6K | 24,701 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2014-05-01 | 2014-05-05 | 666 | $59.55 | $39.7K | 25,380 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2014-04-30 | 2014-05-05 | 666 | $29.70 | $19.8K | 26,046 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2014-03-06 | 2014-03-10 | 2,558 | — | $0 | 3,125 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2014-03-06 | 2014-03-10 | 14,812 | — | $0 | 5,258 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2014-03-06 | 2014-03-10 | 2,558 | $21.51 | $55.0K | 27,938 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2014-03-06 | 2014-03-10 | 14,812 | $28.23 | $418.1K | 42,750 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2014-03-06 | 2014-03-10 | 17,370 | $78.63 | $1.37M | 25,380 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2014-02-14 | 2014-02-19 | 10,500 | — | $0 | 25,380 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2013-12-09 | 2013-12-11 | 84 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2013-12-09 | 2013-12-11 | 625 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2013-12-09 | 2013-12-11 | 9,192 | — | $0 | 625 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2013-12-09 | 2013-12-11 | 3,125 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2013-12-09 | 2013-12-11 | 13,026 | $69.55 | $906.0K | 14,880 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2013-12-09 | 2013-12-11 | 9,192 | $21.51 | $197.7K | 27,906 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2013-12-09 | 2013-12-11 | 3,750 | $14.39 | $54.0K | 18,714 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2013-12-09 | 2013-12-11 | 84 | $17.86 | $1.5K | 14,964 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2013-11-01 | 2013-11-05 | 99 | $63.16 | $6.3K | 14,880 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2013-10-31 | 2013-11-05 | 99 | $27.91 | $2.8K | 14,979 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2013-06-03 | 2013-06-04 | 493 | $58.34 | $28.8K | 14,880 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2013-05-31 | 2013-06-04 | 297 | $62.70 | $18.6K | 15,373 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2013-05-15 | 2013-05-17 | 49,000 | — | $0 | 49,000 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2013-05-15 | 2013-05-17 | 8,400 | — | $0 | 15,670 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2013-05-13 | 2013-05-14 | 1,248 | $69.26 | $86.4K | 7,270 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2013-05-12 | 2013-05-14 | 752 | $67.68 | $50.9K | 8,518 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2013-05-09 | 2013-05-10 | 811 | $66.00 | $53.5K | 9,270 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2013-05-08 | 2013-05-10 | 489 | $65.32 | $31.9K | 10,081 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2013-05-01 | 2013-05-03 | 797 | $64.52 | $51.4K | 10,570 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2013-04-30 | 2013-05-03 | 797 | $23.20 | $18.5K | 11,367 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2013-04-19 | 2013-04-23 | 5,000 | — | $0 | 15,500 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2013-04-19 | 2013-04-23 | 5,000 | $21.51 | $107.6K | 15,570 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2013-04-19 | 2013-04-23 | 5,000 | $65.00 | $325.0K | 10,570 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2013-03-04 | 2013-03-06 | 4,000 | — | $0 | 20,500 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2013-03-04 | 2013-03-06 | 4,000 | $60.00 | $240.0K | 10,570 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2013-03-04 | 2013-03-06 | 4,000 | $21.51 | $86.0K | 14,570 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2013-01-22 | 2013-01-24 | 3,000 | — | $0 | 93,034 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2013-01-22 | 2013-01-24 | 3,000 | $55.00 | $165.0K | 10,570 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2013-01-22 | 2013-01-24 | 3,000 | $21.51 | $64.5K | 13,570 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2012-11-28 | 2012-11-30 | 2,500 | — | $0 | 99,450 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2012-11-28 | 2012-11-30 | 916 | — | $0 | 98,534 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2012-11-28 | 2012-11-30 | 2,500 | — | $0 | 96,034 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2012-11-28 | 2012-11-30 | 2,500 | $14.39 | $36.0K | 13,070 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2012-11-28 | 2012-11-30 | 5,916 | $48.31 | $285.8K | 10,570 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2012-11-28 | 2012-11-30 | 2,500 | $21.51 | $53.8K | 16,486 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2012-11-28 | 2012-11-30 | 916 | $17.86 | $16.4K | 13,986 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2012-11-12 | 2012-11-14 | 265 | $48.11 | $12.7K | 10,570 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2012-10-31 | 2012-11-14 | 265 | $21.76 | $5.8K | 10,835 | SEC↗ |